Drug Pipeline

FDA Updates: Ofatumumab for MS, More Data Needed for Filgotinib in RA, Hearing Set for ALKS 3831

August 23, 2020

FDA actions for the week ending August 21, 2020, include a hearing set for a drug that could limit weight gain often associated with treatment for serious mental illness.

FDA Updates: Treatment for Duchenne Mutation, Gilead Seeks Remdesivir Approval, Data on ALKS 3831

August 16, 2020

Actions from FDA this week include approval of a second targted treatment for a Duchenne muscular dystrophy mutation, and filings in COVID-19 and blood disorders.

FDA Updates: Blood Cancers, Orphan Drug Designations Get Priority

August 02, 2020

In a busy week, FDA approved ground-breaking therapies in hematologic cancers and issued Orphan Drug designations in areas of significant unmet need.

New Drugs Take Aim at Autoimmune Diseases

July 31, 2020

Potential agents to battle inflammation and other processes move through development pipeline.

Our Coverage of the Race to Develop a COVID-19 Vaccine

July 29, 2020

As several COVID-19 vaccine candidates are now in the late phase of clinical trials, MHE is sharing a few stories that have covered the infamous virus' vaccine development journey.

Sandoz, Boehringer Ingelheim Battle Biosimilar Misinformation

July 24, 2020

Biosimilar misinformation takes many forms, some of it institutionalized in the form of word usage and some of it deliberately disparaging, 2 executives of Sandoz and Boehringer Ingelheim contend.

Famed AIDS Researcher Finds That the Sickest Patients Could Hold the Key to Beating COVID-19

July 23, 2020

Dr. David Ho, who developed the HIV cocktail, has isolated antibodies he says could be used to create treatments for COVID-19.

How Will Real-World Evidence Help Drive Solutions for COVID-19?

July 19, 2020

How real-world evidence will help FDA develop a vaccine.

It's Possible for Those Who Practice, Pay for Precision Oncology to Catch Up to Speed of Innovation

July 14, 2020

The fast-evolving field of precision medicine offers the promise of more effective treatments and better outcomes, and it’s time that we collaborate to keep outdated clinical and reimbursement practices from slowing it down.

Is Combination Therapy on the Horizon in Diabetic Macular Edema?

July 12, 2020

Patients with diabetic macular edema whose vision remains impaired even with the best available treatments may soon have a combination therapy.

FDA Updates: Brilinta’s Priority Review in Stroke; Biogen’s Alzheimer’s BLA; Mytesi IND in Cancer Care

July 11, 2020

Drug development in key areas of unmet need hit milestones this week, with Biogen, AstraZeneca, and Jaguar Health announcing regulatory steps with the FDA.

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

July 01, 2020

In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.

Express Scripts Report: Top Drug Classes Driving Spending Growth

February 26, 2020

Express Scripts’ annual Drug Trend Report highlights top contributors to prescription drug spending in 2019.

The Most Valuable Pipeline Drugs For 2020

January 01, 2020

Here are the top drugs expected to be approved this year and their financial impact.

Top Women’s and Men’s Cancer Treatment Developments

September 13, 2019

From breast cancer to prostate cancer, the state of oncology care and how it will evolve.

Life-Altering Gene Therapy Pipeline Poses Challenges

September 05, 2019

What to expect for these high-dollar drugs.

What You Need to Know About the Vaccine Pipeline

June 02, 2019

The vaccines that could make a big impact on healthcare, from radical new flu vaccines to simplified meningococcal vaccine regimens.

Five Ways Diabetes Treatments are Changing

April 02, 2019

The disease management and insurer initiatives changing the diabetes landscape.

Novel Therapies Mitigate High-Cost Rheumatoid Arthritis Treatment

March 01, 2019

The latest in RA therapies, and what you can expect from the pipeline.